TY - JOUR
T1 - Fungal silver nanoparticles
T2 - synthesis, application and challenges
AU - Zhao, Xixi
AU - Zhou, Liangfu
AU - Riaz Rajoka, Muhammad Shahid
AU - Yan, Lu
AU - Jiang, Chunmei
AU - Shao, Dongyan
AU - Zhu, Jing
AU - Shi, Junling
AU - Huang, Qingsheng
AU - Yang, Hui
AU - Jin, Mingliang
N1 - Publisher Copyright:
© 2017, © 2017 Informa UK Limited, trading as Taylor & Francis Group.
PY - 2018/8/18
Y1 - 2018/8/18
N2 - Purpose: This paper aims to summarize recent developments regarding the synthesis, application and challenges of fungal AgNPs. Possible methods to overcome the challenge of synthesis and reduce the toxicity of AgNPs have been discussed. Materials and methods: This review consults and summary a large number of papers. Results: Silver nanoparticles (AgNPs) have great potential in many areas, as they possess multiple novel characteristics. Conventional methods for AgNPs biosynthesis involve chemical agents, causing environmental toxicity and high energy consumption. Fungal bioconversion is a simple, low-cost and energy-efficient biological method, which could successfully be used for AgNPs synthesis. Fungi can produce enzymes that act as both reducing and capping agents, to form stable and shape-controlled AgNPs. Conclusions: AgNPs have great potential in the medical and food industries, due to their antimicrobial, anticancer, anti-HIV, and catalytic activities. However, the observed in vitro and in vivo toxicity poses considerable challenges in the synthesis and application of AgNPs.
AB - Purpose: This paper aims to summarize recent developments regarding the synthesis, application and challenges of fungal AgNPs. Possible methods to overcome the challenge of synthesis and reduce the toxicity of AgNPs have been discussed. Materials and methods: This review consults and summary a large number of papers. Results: Silver nanoparticles (AgNPs) have great potential in many areas, as they possess multiple novel characteristics. Conventional methods for AgNPs biosynthesis involve chemical agents, causing environmental toxicity and high energy consumption. Fungal bioconversion is a simple, low-cost and energy-efficient biological method, which could successfully be used for AgNPs synthesis. Fungi can produce enzymes that act as both reducing and capping agents, to form stable and shape-controlled AgNPs. Conclusions: AgNPs have great potential in the medical and food industries, due to their antimicrobial, anticancer, anti-HIV, and catalytic activities. However, the observed in vitro and in vivo toxicity poses considerable challenges in the synthesis and application of AgNPs.
KW - AgNP
KW - bioactivity
KW - biosynthesis
KW - Fungi
KW - mechanism
KW - potential utilization
KW - toxicity
UR - https://www.scopus.com/pages/publications/85038355807
U2 - 10.1080/07388551.2017.1414141
DO - 10.1080/07388551.2017.1414141
M3 - 文献综述
C2 - 29254388
AN - SCOPUS:85038355807
SN - 0738-8551
VL - 38
SP - 817
EP - 835
JO - Critical Reviews in Biotechnology
JF - Critical Reviews in Biotechnology
IS - 6
ER -
